戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 LCAT), which rapidly converts cholesterol to cholesteryl ester.
2 ne, phosphatidylserine, triacylglycerol, and cholesteryl ester.
3 ncrease in the synthesis of phospholipid and cholesteryl ester.
4 ture of steroidogenic luteal cells and store cholesteryl esters.
5 d from other condensed structures, including cholesteryl esters.
6 ompanied by a compensatory overproduction of cholesteryl esters.
7 two enzymes that convert free cholesterol to cholesteryl esters.
8 for neutral lipids such as triglycerides and cholesteryl esters.
9 cholines, quaternary amines, and cholesteryl/cholesteryl esters.
10 in the duodenal hydrolysis and absorption of cholesteryl esters.
11 ase, leading to a subsequent accumulation of cholesteryl esters.
12 gh arachidonic acid and low linoleic acid in cholesteryl esters.
13 gths-540 and 560 nm (calcification), 920 nm (cholesteryl ester), 1040 nm (phospholipids), 1180 nm (el
14                           Relevant amount of cholesteryl esters (14.3-15.6%) were also detected.
15 ipids, 23% for glycerophospholipids, 16% for cholesteryl esters, 15% for sphingolipids, and 9% for he
16 h as in atherosclerosis, excessive levels of cholesteryl ester accumulate in lysosomes for reasons th
17 ell formation assessed by lipid staining and cholesteryl ester accumulation compared with control cel
18 therosclerosis in LDLR(-/-) mice by reducing cholesteryl ester accumulation in atherosclerotic sites.
19 When fed a Western-type diet, hepatic TG and cholesteryl ester accumulation was significantly higher
20 osclerotic plaque macrophages, ACAT promotes cholesteryl ester accumulation, resulting in foam cell f
21 P1 and anti-P2 Abs in reducing intracellular cholesteryl ester accumulation.
22 tected against hepatic neutral lipid (TG and cholesteryl ester) accumulation, with the greatest diffe
23 sphatidylcholines (LPCs), sphingolipids, and cholesteryl esters all showed delayed increases at day 7
24                Enrichment of microsomes with cholesteryl esters also inhibits cholesterol ester synth
25 in, markedly raises high-density lipoprotein-cholesteryl ester and has no effect on fecal cholesterol
26 R-mitochondrial communication-as measured by cholesteryl ester and phospholipid synthesis, respective
27 ing in quantifying two major neutral lipids: cholesteryl ester and triacylglycerol in cells and tissu
28 L gene-knockout (lal(-/-)) mice, blockage of cholesteryl ester and triglyceride metabolism led to abn
29 P) is a serum component responsible for both cholesteryl ester and triglyceride trafficking between h
30 s essential for the clearance of endocytosed cholesteryl ester and triglyceride-rich chylomicron remn
31 r protein (CETP) facilitates the transfer of cholesteryl ester and triglycerides between plasma lipop
32         HL-HDLs presented a core enriched in cholesteryl esters and a surface depleted of phosphatidy
33 ons and VLDL that are relatively enriched in cholesteryl esters and apolipoprotein (apo)E.
34  Conditional genetic ablation of MTP reduces cholesteryl esters and enhances free cholesterol in the
35 e 1 (Acat1) converts cellular cholesterol to cholesteryl esters and is considered a drug target for t
36 f fat in the liver showed an accumulation of cholesteryl esters and of triglycerides.
37  (ARIC) Study analyzed plasma fatty acids in cholesteryl esters and phospholipids in whites residing
38 ent LAL activity accumulate large amounts of cholesteryl esters and triglycerides in multiple tissues
39 ase (LAL) is essential for the hydrolysis of cholesteryl esters and triglycerides to generate cholest
40          Lysosomal acid lipase (LAL) cleaves cholesteryl esters and triglycerides to generate free fa
41 id lipase (LAL) is a key enzyme that cleaves cholesteryl esters and triglycerides to generate free fa
42       Lysosomal acid lipase (LAL) hydrolyzes cholesteryl esters and triglycerides to generate free fa
43 id accumulation and storage of oxidized LDL, cholesteryl esters and triglycerides were abolished in H
44 her HDL components, such as apolipoproteins, cholesteryl esters and triglycerides.
45 e LAL inhibitor increased the levels of TAG, cholesteryl ester, and RE in both rat and mouse HSCs.
46  substrates tested, including phospholipids, cholesteryl ester, and retinyl esters.
47 copy for the quantitative analysis of waxes, cholesteryl esters, and glycerides in meibum lipid (ML).
48 lipids (including lyso- and ether- species), cholesteryl esters, and glycerolipids were associated wi
49 cylglycerols, 1,2-diol diesters, wax esters, cholesteryl esters, and hydrocarbons, from TLC and high-
50  such as oxidized phospholipids and oxidized cholesteryl esters, and mediate a variety of immune resp
51 , plasma phosphatidylcholine, triglycerides, cholesteryl esters, and nonesterified fatty acids).
52                               Sphingolipids, cholesteryl esters, and phospholipids were associated wi
53 hosphatidylcholine-lipid species and gaining cholesteryl esters, and proteomic changes, with losses i
54 ts (LDs) containing triacylglycerols (TAGs), cholesteryl esters, and retinyl esters (REs).
55 ing di- and triacylglycerols, phospholipids, cholesteryl esters, and wax esters in OG-treated sebocyt
56  GD3 and GD1a), cardiolipin, cholesterol and cholesteryl esters are elevated in autophagic vacuole fr
57              In hepatocytes and enterocytes, cholesteryl esters are secreted as part of apoB lipoprot
58 using TAG, phospholipids, galactolipids, and cholesteryl esters as substrates.
59 rate stimulated the synthesis of unsaturated cholesteryl esters at the expense of saturated esters.
60 P) facilitates exchange of triglycerides and cholesteryl ester between high-density lipoprotein (HDL)
61 refore, MTP plays a novel role in regulating cholesteryl ester biosynthesis in cells that produce lip
62 to alleviate product inhibition and modulate cholesteryl ester biosynthesis.
63  or longer does not impair the hydrolysis of cholesteryl esters but partially impairs the transport o
64         Finally, the clearance of plasma HDL cholesteryl ester, but not HDL protein, was faster in CB
65 ng 2 amino acids (citrulline and glycine), 4 cholesteryl esters (C18:2, C18:1, C16:0, C18:3), 8 phosp
66 l metabolism-associated lipids [arachidonoyl cholesteryl ester, C8-dihydroceramide, N-stearoyl-d-sphi
67 intima, contributes to massive intracellular cholesteryl ester (CE) accumulation in human vascular sm
68 il to clear myelin cholesterol, resulting in cholesteryl ester (CE) accumulation.
69                                              Cholesteryl ester (CE) and diacylglycerol (DAG) molecula
70       Lysosomal acid lipase (LAL) hydrolyzes cholesteryl ester (CE) and retinyl ester (RE) and trigly
71 eryl ester transfer protein (CETP) transfers cholesteryl ester (CE) and triglyceride (TG) between lip
72 ed O-stained foam cells and showed increased cholesteryl ester (CE) content when cocultured with LDL.
73 ticles or via selective uptake (SU), wherein cholesteryl ester (CE) enters cells without concomitant
74 cal activities of mmLDL were associated with cholesteryl ester (CE) hydroperoxides and were diminishe
75  quantification of free cholesterol (FC) and cholesteryl ester (CE) in mammalian samples is of great
76 l-CoA and cholesterol are two substrates for cholesteryl ester (CE) synthesis via the ACAT reaction.
77 tent CETP inhibitor that maximally inhibited cholesteryl ester (CE) transfer activity at an oral dose
78 pment of protocols for the direct measure of cholesteryl ester (CE) transfer activity resident in hum
79 ked selective high-density lipoprotein (HDL) cholesteryl ester (CE) transport and steroidogenesis.
80  by selective high density lipoprotein (HDL)-cholesteryl ester (CE) uptake, mediated by scavenger rec
81          Isolation of free cholesterol (FC), cholesteryl ester (CE), and triglyceride (TG) from plasm
82                           Elevated levels of cholesteryl ester (CE)-enriched apoB containing plasma l
83 cithin:cholesterol acyltransferase (LCAT) is cholesteryl ester (CE).
84 e different CD1c conformations and suggested cholesteryl esters (CE) and acylated steryl glycosides (
85                Recombinant (r) SOF transfers cholesteryl esters (CE) from approximately 400,000 HDL p
86 otein liquid chromatography profiles, aortic cholesteryl esters (CE), and plaque sizes were determine
87  lipid mixture of triacylglycerols (TAG) and cholesteryl esters (CE), surrounded by a single monolaye
88 AD-patient iPSC-derived neurons and identify cholesteryl esters (CE), the storage product of excess c
89 ajor lipid classes, such as wax esters (WE), cholesteryl esters (CE), triacylglycerols, (O)-acylated
90 nt HDL receptor that mediates removal of HDL-cholesteryl esters (CE).
91 36:5, 38:5), lyso-PCs (16:1, 18:1, 22:4) and cholesteryl esters (CEs) (16:0, 18:0, 20:4) in fish from
92 hydrolysis of high-density lipoprotein (HDL) cholesteryl esters (CEs) after selective uptake by hepat
93 rvention on plasma fatty acid composition of cholesteryl esters (CEs) and phospholipids and estimated
94 lyzes the hydrolysis of intracellular stored cholesteryl esters (CEs) and thereby enhances free chole
95 sfer protein (CETP) mediates the transfer of cholesteryl esters (CEs) and triglycerides between diffe
96                              Accumulation of cholesteryl esters (CEs) in macrophage foam cells, centr
97 binds HDL and mediates selective delivery of cholesteryl esters (CEs) to the liver, adrenals, and gon
98 of lipid species, that is, wax esters (WEs), cholesteryl esters (CEs), and diesters (DEs) were correc
99 major compounds, triacylglycerols (TAGs) and cholesteryl esters (CEs), inside lipid droplets (LDs).
100 M map lead to a juxtaposed stacking model of cholesteryl esters (CEs).
101 el wherein after lysosomal hydrolysis of LDL-cholesteryl esters, cholesterol binds NPC2, which transf
102 t pathway, but has no effect on total plasma cholesteryl ester clearance.
103 cquire cholesterol in part by endocytosis of cholesteryl ester containing lipoproteins.
104  macrophages and decreased the intracellular cholesteryl ester content.
105                               The changes in cholesteryl ester could be used as a molecular marker fo
106                                 The level of cholesteryl esters decreased, and after a pronounced lag
107 l ester transfer protein mediates direct HDL cholesteryl ester delivery to the liver cells; adipose t
108  demonstrate the presence of cholesterol and cholesteryl ester deposits beneath the retinal pigment e
109 h as keto, hydroperoxide, hydroxy, and epoxy cholesteryl ester derivatives from cholesteryl linoleate
110 c acid (20:4n-6) in plasma phospholipids and cholesteryl esters differed between genotype groups (int
111 osed primarily of TG, with lesser amounts of cholesteryl esters, diglyceride and other phospholipids.
112 rption by the intestine and the secretion of cholesteryl ester-enriched very low density lipoproteins
113                                       Plasma cholesteryl esters followed a similar time course as HDL
114 he esterification of cholesterol to generate cholesteryl esters for cholesterol storage.
115 RD4 has been shown to increase intracellular cholesteryl ester formation and is controlled at the tra
116             Mutant line A1 displayed reduced cholesteryl ester formation from PM-derived cholesterol
117 rol acyltransferase-mediated (LCAT-mediated) cholesteryl ester formation in media.
118 n in vivo, with significant reduction in HDL cholesteryl ester formation.
119 ze HDL particles and prevent the transfer of cholesteryl ester from HDL to atherogenic lipoproteins.
120        CETP inhibitors block the transfer of cholesteryl ester from HDLs to triglyceride-rich lipopro
121 fer protein (CETP) catalyzes the transfer of cholesteryl ester from high-density lipoprotein (HDL) to
122 r protein inhibitors prevent the transfer of cholesteryl ester from high-density lipoprotein to trigl
123 ryl ester transfer protein (CETP) transports cholesteryl ester from the antiatherogenic high-density
124 otein (CETP), which mediates the transfer of cholesteryl esters from HDL to apolipoprotein B-containi
125 eryl ester transfer protein (CETP) transfers cholesteryl esters from high-density lipoproteins to apo
126                      The characterization of cholesteryl esters from TG fraction of human plasma samp
127 lular cholesterol esterification by removing cholesteryl esters from their site of synthesis and depo
128  cellular selective uptake of lipids, mainly cholesteryl esters, from HDL.
129                                              Cholesteryl ester hydrolase (CEH) catalyzes the hydrolys
130 olesterol acyltransferase, ACAT, the neutral cholesteryl ester hydrolase (nCEH) that catalyzes the re
131  lysosomes enhanced, and lipoprotein-derived cholesteryl ester hydrolysis accelerated.
132                                        Thus, cholesteryl ester hydrolysis can occur extracellularly i
133 us nCEH that can account for the majority of cholesteryl ester hydrolysis in transformed rat hepatic
134                 These data also suggest that cholesteryl ester hydroperoxides are an endogenous ligan
135 ts with chronic inflammatory conditions, and cholesteryl ester hydroperoxides are present in plasma,
136 report that mmLDL and its active components, cholesteryl ester hydroperoxides, induce TLR4-dependent
137 up to 70-fold increases in specific oxidized cholesteryl esters, identical to those present in human
138 oscopy, we found an aberrant accumulation of cholesteryl ester in human pancreatic cancer specimens a
139 though esterification of free cholesterol to cholesteryl ester in the liver is known to be catalyzed
140 eeply within the protein, shifting the bound cholesteryl ester in the N-terminal pocket of the long h
141 an increase of phosphatidylcholine ether and cholesteryl esters in CD11c(+) immune cells.
142 fere with SR-BI-mediated selective uptake of cholesteryl esters in hepatocytes.
143 wed excellent inhibition of the oxidation of cholesteryl esters in human low-density lipoprotein and
144 uantify the amount of waxes, glycerides, and cholesteryl esters in human meibum.
145              The similarity of the levels of cholesteryl esters in infant meibum and Md suggests that
146        Interestingly, the relative levels of cholesteryl esters in infant meibum were comparable to t
147 or-mediated uptake of LDL, hydrolysis of LDL-cholesteryl esters in lysosomes, and transfer of the lib
148                       The relative amount of cholesteryl esters in Mn increased with age and was 40%
149 ive lipase (HSL) catalyzes the hydrolysis of cholesteryl esters in steroidogenic tissues and, thus, f
150                               The buildup of cholesteryl esters in the cytosol is expected to be much
151 ficient animals synthesize lesser amounts of cholesteryl esters in vitro, but addition of purified MT
152 sease, where the accumulation of cholesterol/cholesteryl-esters in macrophages can elicit a maladapti
153 olecules with apoA-I residues indicates that cholesteryl esters interact with protein residues mainly
154 te selective uptake or influx of HDL-derived cholesteryl esters into cells and tissues.
155               We show that net hydrolysis of cholesteryl ester is coupled to the transfer of choleste
156 ice had larger plasma HDLs enriched in apoM, cholesteryl ester, lecithin:cholesterol acyltransferase,
157 nous HSL, with siRNAs, resulted in increased cholesteryl ester levels and decreased cholesterol conte
158 had significantly lower free cholesterol and cholesteryl ester levels in the brachiocephalic artery t
159 en-2, amylase-2, elastase-1, elastase-2, and cholesteryl-ester lipase.
160 ction force (CTF) transducer system based on cholesteryl ester liquid crystals (LC).
161 e numbers and diminished the cholesterol and cholesteryl ester load without causing detectable apopto
162 ts, histological analysis, and intracellular cholesteryl ester measurements were performed.
163 ere, we have studied endosomal and lysosomal cholesteryl ester metabolism in cultured mouse macrophag
164 nteractions with the protein and the shifted cholesteryl ester molecule.
165 esterol, which creates a hydrophobic core of cholesteryl ester molecules in the middle of the discoid
166 itionally, the average number of contacts of cholesteryl ester molecules with apoA-I residues indicat
167 (NES) = 2.01, P = 0.001, FDR P = 0.005], and cholesteryl esters (NES = -1.77, P = 0.005, FDR P = 0.02
168 lipids - cholesteryl esters, wax esters, and cholesteryl esters of (O)-acylated w-hydroxy fatty acids
169 xy fatty acids (OAHFA), cholesteryl sulfate, cholesteryl esters of OAHFA, and diacylated alpha,omega-
170 f oxidized phospholipids (OxPL) and oxidized cholesteryl esters (OxCE) was evaluated in 24 filters us
171 ules cover the hydrophobic core comprised of cholesteryl esters particularly well.
172 ated with ezetimibe showed a 173% higher LDL-cholesteryl ester plasma disappearance rate (P < 0.001 v
173 group, FA markers in total plasma TG, plasma cholesteryl esters, plasma phospholipids, and red blood
174 ase (LCAT) catalyzes the formation of plasma cholesteryl ester, plays a key role in high-density lipo
175 roups from triglycerides, phospholipids, and cholesteryl esters plus total cholesterol (i.e., both es
176 ated LDs contained nearly all of the TGs and cholesteryl esters present in luteal tissue.
177 The objective was to study whether the serum cholesteryl ester proportion of palmitoleic acid [16:1n-
178 significantly altered lipoprotein lipase and cholesteryl ester protein mass or measures of insulin re
179 ) convert cholesterol into its storage form, cholesteryl esters, regulating a key step in cellular ch
180 high density lipoprotein (HDL) to spheroidal cholesteryl ester-rich HDL is a central step in reverse
181 ccumulation of apolipoprotein B48-containing cholesteryl ester-rich lipoproteins.
182 the partial disproportionation of HDL into a cholesteryl ester-rich microemulsion (CERM) and a new HD
183 D approximately 8.5 nm) into a single, large cholesteryl ester-rich microemulsion (CERM; D > 100 nm),
184 ient HDL-like particles and small amounts of cholesteryl ester-rich microemulsions (CERMs).
185 ss spectrometric profiles of diester wax and cholesteryl ester species.
186                                              Cholesteryl ester storage disease (CESD) and Wolman dise
187                                              Cholesteryl ester storage disease (CESD), an inherited d
188  existing literature on Wolman's disease and cholesteryl ester storage disease, and discuss available
189                                              Cholesteryl ester storage disorder arises later in life
190 plasmic reticulum, where it was converted to cholesteryl esters stored in lipid droplets when ORP1L w
191 ny organs, resulting in a marked increase in cholesteryl esters, suppression of C but not fatty acid
192                                              Cholesteryl ester synthesis by the acyl-CoA:cholesterol
193 y transfected with ACAT1 and ACAT2 increases cholesteryl ester synthesis.
194 y demonstrated that the parasite expresses a cholesteryl ester-synthesizing enzyme, TgACAT1.
195 long-chain fatty acid to cholesterol to form cholesteryl esters that coalesce into cytosolic lipid dr
196 mixture of phospholipids, triglycerides, and cholesteryl esters that plays a major role in lipoprotei
197 m acyl-coenzyme A to cholesterol to generate cholesteryl ester, the primary form in which cholesterol
198 es enzymes of this family to readily oxidize cholesteryl esters, thus providing an additional source
199 eding an HCD supplemented with a fluorescent cholesteryl ester to optically transparent fli1:EGFP zeb
200             The treatment also decreased the cholesteryl ester to total cholesterol ratio (CE/TC), ca
201            LDL enter the endosomes, allowing cholesteryl esters to be hydrolyzed by acid lipase.
202                              Some aspects of cholesteryl ester transfer function can be maintained in
203                                   Inhibiting cholesteryl ester transfer protein (CETP) activity raise
204                        Dalcetrapib modulates cholesteryl ester transfer protein (CETP) activity to ra
205  cholesterol (HDL-C) levels by inhibition of cholesteryl ester transfer protein (CETP) activity with
206                                    rs5882 in cholesteryl ester transfer protein (CETP) and rs4148217
207                            The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib
208                                              Cholesteryl ester transfer protein (CETP) catalyzes the
209 ockout mice, and human apolipoprotein (apo)B/cholesteryl ester transfer protein (CETP) double transge
210                                              Cholesteryl ester transfer protein (CETP) facilitates ex
211                                              Cholesteryl ester transfer protein (CETP) facilitates th
212          DNA sequence variants that decrease cholesteryl ester transfer protein (CETP) gene activity
213                         Polymorphisms in the cholesteryl ester transfer protein (CETP) gene have been
214 is study was to identify associations of the cholesteryl ester transfer protein (CETP) gene with coro
215 xplore two HDL-C raising target modulations, Cholesteryl Ester Transfer Protein (CETP) inhibition and
216 ofuroquinoline derivatives exhibiting potent cholesteryl ester transfer protein (CETP) inhibition at
217 ne is consistent with a protective effect of cholesteryl ester transfer protein (CETP) inhibition on
218                                              Cholesteryl ester transfer protein (CETP) inhibition red
219                 Individuals treated with the cholesteryl ester transfer protein (CETP) inhibitor anac
220 te the efficacy and safety of torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, in
221                               Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, inc
222                                              Cholesteryl ester transfer protein (CETP) inhibitors (JT
223                     Interest remains high in cholesteryl ester transfer protein (CETP) inhibitors as
224                                       Potent cholesteryl ester transfer protein (CETP) inhibitors hav
225                                         Some cholesteryl ester transfer protein (CETP) inhibitors low
226                                              Cholesteryl ester transfer protein (CETP) inhibitors rai
227 cuses on the studies with niacin and the new cholesteryl ester transfer protein (CETP) inhibitors tor
228 mine the recent advances in our knowledge of cholesteryl ester transfer protein (CETP) inhibitors, he
229 is has been challenged by clinical trials of cholesteryl ester transfer protein (CETP) inhibitors, wh
230                                              Cholesteryl ester transfer protein (CETP) is a serum com
231                            The inhibition of cholesteryl ester transfer protein (CETP) is considered
232             We addressed the hypothesis that cholesteryl ester transfer protein (CETP) is mainly deri
233          Genetic deficiency or inhibition of cholesteryl ester transfer protein (CETP) leads to a mar
234                                              Cholesteryl ester transfer protein (CETP) mediates the t
235                                              Cholesteryl ester transfer protein (CETP) mediates the t
236                                          The cholesteryl ester transfer protein (CETP) plays an integ
237                                Inhibition of cholesteryl ester transfer protein (CETP) raises HDL cho
238                                              Cholesteryl ester transfer protein (CETP) transfers chol
239                                              Cholesteryl ester transfer protein (CETP) transfers chol
240                                 Human plasma cholesteryl ester transfer protein (CETP) transports cho
241                                              Cholesteryl ester transfer protein (CETP), bactericidal/
242                            Inhibition of the cholesteryl ester transfer protein (CETP), which mediate
243  of compound (S)-9, which is an inhibitor of cholesteryl ester transfer protein (CETP).
244 Asp), apolipoprotein E (Apo E2, E3, and E4), cholesteryl ester transfer protein (TaqIB), and leptin r
245           The TMD-VOO intervention decreased cholesteryl ester transfer protein activity (relative to
246 ty, HDL ability to esterify cholesterol, and cholesteryl ester transfer protein activity), HDL antiox
247 ding expression of the emerging drug targets cholesteryl ester transfer protein and apolipoprotein (a
248 tigate the mechanisms of action, we measured cholesteryl ester transfer protein and indexes of plasma
249                                       Plasma cholesteryl ester transfer protein and phospholipid tran
250  identified a rare missense variant in CETP (cholesteryl ester transfer protein gene; rs1800777-A) th
251                                Inhibition of cholesteryl ester transfer protein has been shown to red
252         Two small molecule inhibitors of the cholesteryl ester transfer protein have shown promise in
253 s; adipose tissue-specific overexpression of cholesteryl ester transfer protein in mice reduces the p
254     Initial studies addressing the effect of cholesteryl ester transfer protein inhibition on cardiov
255                             Anacetrapib is a cholesteryl ester transfer protein inhibitor that raises
256 and low-density lipoprotein cholesterol, the cholesteryl ester transfer protein inhibitor torcetrapib
257                               Torcetrapib (a cholesteryl ester transfer protein inhibitor) increases
258 s after ACS to treatment with dalcetrapib (a cholesteryl ester transfer protein inhibitor) or placebo
259 te the safety and efficacy of anacetrapib, a cholesteryl ester transfer protein inhibitor, in patient
260 , 0.94-1.09) vs 0.90 (95% CI, 0.89-0.91) for cholesteryl ester transfer protein inhibitors (P = .002)
261                                 As of yet, 2 cholesteryl ester transfer protein inhibitors are still
262                                              Cholesteryl ester transfer protein inhibitors prevent th
263 apeutic agents such as fibrates, niacin, and cholesteryl ester transfer protein inhibitors that are k
264 t should be possible to develop more optimal cholesteryl ester transfer protein inhibitors that do no
265 less, drugs that raise HDL-C concentrations, cholesteryl ester transfer protein inhibitors, are in la
266                           Accordingly, other cholesteryl ester transfer protein inhibitors, if they l
267 specific and, since the crystal structure of cholesteryl ester transfer protein is now known, it shou
268                                              Cholesteryl ester transfer protein mediates direct HDL c
269         One inhibitor, torcetrapib, binds to cholesteryl ester transfer protein on high-density lipop
270 hat do not form a nonproductive complex with cholesteryl ester transfer protein on the high-density l
271 zed in the presence of PLA2 by the action of cholesteryl ester transfer protein or by guanidine hydro
272                                          The cholesteryl ester transfer protein risk variant (rs17231
273 holesterol concentration and adipocyte size; cholesteryl ester transfer protein TaqIB polymorphism is
274                                Unexpectedly, cholesteryl ester transfer protein was not required to d
275  for hepatic lipase, endothelial lipase, and cholesteryl ester transfer protein were analyzed, patien
276 lemia that were naturally deficient in CETP (cholesteryl ester transfer protein) and fed a Western-ty
277      RATIONALE: Therapies that inhibit CETP (cholesteryl ester transfer protein) have failed to demon
278                     The development of CETP (cholesteryl ester transfer protein) inhibitors has had a
279 polipoproteins E, C1, C4, and C2), and CETP (Cholesteryl Ester Transfer Protein).
280  of coexpression of scavenger receptor BI or cholesteryl ester transfer protein, both of which promot
281 frequency for the TaqI B1/B2 polymorphism in cholesteryl ester transfer protein, consistent with the
282  lipoprotein-cholesterol, i.e. inhibition of cholesteryl ester transfer protein, is markedly effectiv
283 -cholesterol fractional esterification rate, cholesteryl ester transfer protein, phospholipid transfe
284 translocated through caveolae were detected (cholesteryl ester, triacylglycerol) and/or enriched (cho
285 se of nonpolar lipids, including wax esters, cholesteryl esters, triacylglycerols, and diesters, wher
286  cholesterol (HDL-C) metabolism in selective cholesteryl ester uptake and in free cholesterol cellula
287                  SR-BI-independent selective cholesteryl ester uptake is a newly characterized pathwa
288      Finally, the SR-B1-linked selective HDL-cholesteryl ester uptake pathway is now being evaluated
289 ion by increasing the rate of HDL-associated cholesteryl ester uptake, possibly by optimizing SR-BI l
290 uding SR-BI-independent macrophage selective cholesteryl ester uptake.
291  I (SR-BI), binds HDL and mediates selective cholesteryl ester uptake.
292 , LpL but not CD36 deficiency decreased VLDL-cholesteryl ester uptake.
293 efflux capacity but reduced clearance of HDL cholesteryl esters versus control mice.
294 cetrapib markedly decreases clearance of HDL cholesteryl ester via an indirect pathway, but has no ef
295 ansferase (LCAT), a key enzyme that produces cholesteryl esters via transfer of acyl groups from phos
296 learance of HDL particles and HDL-associated cholesteryl esters was also similar between hLrp1(+/+) a
297 affected major classes of meibomian lipids - cholesteryl esters, wax esters, and cholesteryl esters o
298                                        Also, cholesteryl esters were detected via adduct formation wi
299 esterol was largely increased by 60-fold and cholesteryl esters were increased by 24-fold.
300                     Phosphatidylcholines and cholesteryl esters were positively correlated with fatty

 
Page Top